本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aura Biosciences, Inc.

6.59
-0.1400-2.08%
成交量:91.64萬
成交額:605.10萬
市值:6.81億
市盈率:-3.72
高:6.88
開:6.84
低:6.46
收:6.73
52周最高:9.54
52周最低:4.73
股本:1.03億
流通股本:7,991.55萬
量比:1.12
換手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-1.7726
每股收益(LYR):-1.7599
淨資產收益率:-53.49%
總資產收益率:-31.24%
市淨率:2.16
市盈率(LYR):-3.74

資料載入中...

2026/09/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/08

重要事件披露

Form 8-K - Current report
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans